#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16350	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2616	766.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1861	1861	T	989	T,G	987,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16350	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2616	766.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1595	1595	C	1017	C	1017	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26890	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3882	861.5	0	.	n	.	0	T695C	SNP	695	695	T	1185	1185	C	1011	C,T,G	1008,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26890	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3882	861.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1827	1827	A	1033	A,G,C	1030,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26890	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3882	861.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2461	2461	C	937	C,G	936,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26890	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3882	861.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2535	2535	A	862	A,G,C	860,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26890	23S	2890	2890	99.9	23S.l15.c17.ctg.1	3882	861.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3087	3087	C	953	C,T	951,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2194	folP	855	855	100.0	folP.l6.c30.ctg.1	2098	130.5	1	SNP	p	R229S	0	.	.	685	687	CGC	1304	1306	CGC	233;232;235	C;G;C	233;232;235	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5218	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3762	172.8	1	SNP	p	S91F	0	.	.	271	273	TCC	773	775	TCC	193;193;193	T;C,G;C	193;192,1;193	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5218	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3762	172.8	1	SNP	p	D95N	0	.	.	283	285	GAC	785	787	GAC	197;197;198	G;A,C;C,G	197;196,1;197,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5218	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3762	172.8	1	SNP	p	D95G	0	.	.	283	285	GAC	785	787	GAC	197;197;198	G;A,C;C,G	197;196,1;197,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	2176	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1894	143.1	1	SNP	p	G45D	1	.	.	133	135	GAC	720	722	GAC	236;239;238	G;A;C	236;239;238	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1192	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1459	101.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5884	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3491	210.4	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1928	1930	GCA	288;289;292	G;C;A	288;289;292	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5884	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3491	210.4	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2411	2413	ATT	265;265;261	A;T;T	265;265;261	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5884	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3491	210.4	1	SNP	p	D86N	0	.	.	256	258	GAC	881	883	GAC	242;239;235	G;A;C	242;239;235	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5884	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3491	210.4	1	SNP	p	S87R	0	.	.	259	261	AGT	884	886	AGT	236;236;235	A;G;T	236;236;235	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5884	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3491	210.4	1	SNP	p	S87I	0	.	.	259	261	AGT	884	886	AGT	236;236;235	A;G;T	236;236;235	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5884	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3491	210.4	1	SNP	p	S87W	0	.	.	259	261	AGT	884	886	AGT	236;236;235	A;G;T	236;236;235	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5884	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3491	210.4	1	SNP	p	S88P	0	.	.	262	264	TCC	887	889	TCC	237;237;238	T,G;C;C	236,1;237;238	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4282	parE	1986	1986	99.9	parE.l15.c4.ctg.1	3129	170.9	0	.	p	.	0	V89A	NONSYN	265	267	GTC	819	821	GCC	189;191;189	G;C;C	189;191;189	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4282	parE	1986	1986	99.9	parE.l15.c4.ctg.1	3129	170.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1782	1784	GGC	254;251;249	G,C;G;C	253,1;251;249	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.1.001	penA.1.001	1	1	27	4006	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2924	170.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1506	1508	GCA	239;241;240	G;C,A;A	239;240,1;240	penA.1.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4006	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2924	170.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1509	1511	ATC	239;242;240	A;T,G,C;C,G	239;240,1,1;239,1	penA.1.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4006	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2924	170.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1521	1523	GTG	240;243;244	G;T,A;G	240;242,1;244	penA.1.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4006	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2924	170.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1521	1523	GTG	240;243;244	G;T,A;G	240;242,1;244	penA.1.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4006	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2924	170.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2025	2027	ACC	238;240;241	A,G;C,T;C	237,1;239,1;241	penA.1.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4006	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2924	170.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2079	2081	GCG	214;213;211	G,A;C,T;G	213,1;212,1;211	penA.1.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4006	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2924	170.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2079	2081	GCG	214;213;211	G,A;C,T;G	213,1;212,1;211	penA.1.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4006	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2924	170.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2202	2204	GGC	239;243;240	G;G,A;C	239;242,1;240	penA.1.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4006	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2924	170.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2211	2213	GGC	247;249;251	G;G;C	247;249;251	penA.1.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.1.001	penA.1.001	1	1	27	4006	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2924	170.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2229	2231	CCG	230;230;225	C,G;C,G;G	229,1;229,1;225	penA.1.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	6090	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3708	205.1	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1976	1978	CTG	250;252;251	C;T;G	250;252;251	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3122	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2415	161.3	0	.	p	.	0	S22G	NONSYN	64	66	AGC	673	675	GGC	235;236;236	G;G,A;C,T	235;235,1;235,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3122	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2415	161.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	855	855	C	241	C	241	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	3010	porB1a	984	984	99.7	porB1a.l6.c17.ctg.1	1845	201.1	0	.	p	.	0	A38D	NONSYN	112	114	GCT	602	604	GAT	211;212;211	G;A;T	211;212;211	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	3010	porB1a	984	984	99.7	porB1a.l6.c17.ctg.1	1845	201.1	0	.	p	.	0	Y39H	NONSYN	115	117	TAC	605	607	CAC	210;208;206	C;A;C	210;208;206	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	3010	porB1a	984	984	99.7	porB1a.l6.c17.ctg.1	1845	201.1	0	.	p	.	0	A44E	NONSYN	130	132	GCG	620	622	GAG	222;225;224	G;A;G,C	222;225;223,1	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10888	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5481	248.2	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2304	2306	CAT	297;294;295	C;A,C;T	297;293,1;295	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1654	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1471	139.5	1	SNP	p	V57M	0	.	.	169	171	GTG	790	792	GTG	309;308;306	G;T,C;G	309;307,1;306	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
